1950
DOI: 10.1016/0002-9343(50)90096-9
|View full text |Cite
|
Sign up to set email alerts
|

Hypercalcemia in osteolytic metastatic cancer of the breast

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
8
0

Year Published

1950
1950
1972
1972

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 45 publications
(8 citation statements)
references
References 12 publications
0
8
0
Order By: Relevance
“…Polyuria and loss of renal concentrating ability have frequently been observed in patients with hypercalcemia (1)(2)(3)(4)(5)(6)(7)(8). It has not been clear whether the capacity of the kidneys to concentrate urine is selectively impaired by hypercalcemia or whether it is depressed together with many other renal functions as a result of substantial injury to and encroachment upon active renal parenchyma (9).…”
mentioning
confidence: 99%
“…Polyuria and loss of renal concentrating ability have frequently been observed in patients with hypercalcemia (1)(2)(3)(4)(5)(6)(7)(8). It has not been clear whether the capacity of the kidneys to concentrate urine is selectively impaired by hypercalcemia or whether it is depressed together with many other renal functions as a result of substantial injury to and encroachment upon active renal parenchyma (9).…”
mentioning
confidence: 99%
“…The calcium balance is much less negative in this patient than is seen in a patient with a predominantly osteolytic type of metastasis, such as metastatic breast carcinoma (8). In agreement with this is the observation of a normal serum calcium; whereas in cases of extensive osteolytic metastasis, hypercalcemia is not infrequently seen (8,11,12 The effect of estrogens upon the calcium, phosphorus and nitrogen metabolism of metabolic bone disease has been carefully studied and described by Gardner and Pfeiffer (13), Reifenstein and Albright (14,15), and others. It has been noted that the effect of the estrogens on protein metabolism is less marked than the effect of androgens.…”
Section: Discussionmentioning
confidence: 73%
“…Hypercalcaemia is a frequent complication in patients with malignant tumours (Woodard, 1953;Swyer, Berger, Gordon and Laszlo, 1950 15) responded to prolothan G therapy while the hypercalcaemia of case 14 wA,as unresponsive to the therapy. It would appear from the normal 47Ca blood-boIne dynamics of the patients studied (cases 6 and 15) that the prolothan G lhad Ino direct effect on the normal exchange and accretion processes in bone precluding any acute parathormone blocking action.…”
Section: Resultsmentioning
confidence: 99%